Diagnostic Utility of a Cost‐Effective Four‐Gene Next Generation Sequencing Panel for Predicting Papillary Thyroid Carcinoma in Indeterminate Thyroid Cytology: A Multicenter Study in China
Cancer Medicine · 2026
DOI: 10.1002/cam4.71924 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Cancer Medicine, 2026. Verfasst von Qiong Jiao und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China. Hauptthemen laut MEDLINE: High-Throughput Nucleotide Sequencing, Thyroid Neoplasms, Thyroid Cancer, Papillary, Biomarkers, Tumor. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China, Nature Science Fund of Science and Technology Commission of Shanghai Municipality, Noncommunicable Chronic Diseases-National Science and Technology Major Project of China.
Abstract (Originalsprache)
Molecular testing has emerged as a pivotal tool for the preoperative assessment of cytologically indeterminate thyroid nodules. In this cross‐sectional study, we evaluated the diagnostic utility of a targeted next‐generation sequencing (NGS) 4‐gene panel, including BRAF V600E , TERT promoter mutations, RET fusions, and NTRK3 fusion, for enhancing the cytological diagnosis of thyroid nodules prior to surgical intervention. A total of 827 thyroid nodules subjected to fine‐needle aspiration and subsequent histopathological confirmation were analyzed, among which 773 (93.5%) were classified as malignant or noninvasive follicular thyroid neoplasm with papillary‐like nuclear features (NIFTP). The observed prevalence of molecular alterations was: BRAF V600E , 68.3% (526/770); TERT promoter mutations, 10.3% (79/770); RET fusions, 10.3% (79/770); and NTRK3 fusion, 3.9% (30/770). Notably, the 4‐gene NGS panel demonstrated brilliant diagnostic performance for indeterminate cytological nodules (Bethesda categories III–V), achieving a sensitivity of 87.9%, specificity of 96.3%, positive predictive value (PPV) of 99.7%, negative predictive value (NPV) of 35.9%, and overall accuracy of 88.2%. These findings indicate that the targeted NGS 4‐gene panel provides high diagnostic precision in distinguishing benign from malignant nodules. Its implementation offers a cost‐effective, efficient molecular diagnostic strategy that may reduce unnecessary diagnostic procedures and facilitate optimized clinical management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pathology, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- Department of Molecule and Pathology, Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, China.
- The Third Affiliated Hospital of Soochow University, Changzhou First People's Hospital, Changzhou, China.
- Shanghai RIGEN Biotechnology co., Ltd., Shanghai, China.
ORCID-Profile: Qiong Jiao, Qing Li, Xuling Su, Yanli Luo, Zhiyan Liu
Förderung
- National Natural Science Foundation of China
- Nature Science Fund of Science and Technology Commission of Shanghai Municipality
- Noncommunicable Chronic Diseases-National Science and Technology Major Project of China
- Shanghai Leading Talent Program of Eastern Talent Plan
- Demonstration program for innovative medical devices and drugs of Shanghai Municipality
Zitieren
APA
Jiao, Q., Wu, L., Wei, B., Li, Q., Su, X., Sun, K., Zhang, X., Luo, Y., & Liu, Z. (2026). Diagnostic Utility of a Cost‐Effective Four‐Gene Next Generation Sequencing Panel for Predicting Papillary Thyroid Carcinoma in Indeterminate Thyroid Cytology: A Multicenter Study in China. Cancer Medicine. https://doi.org/10.1002/cam4.71924
Vancouver
Jiao Q, Wu L, Wei B, Li Q, Su X, Sun K, et al. Diagnostic Utility of a Cost‐Effective Four‐Gene Next Generation Sequencing Panel for Predicting Papillary Thyroid Carcinoma in Indeterminate Thyroid Cytology: A Multicenter Study in China. Cancer Medicine. 2026. doi:10.1002/cam4.71924
BibTeX
@article{Jiao2026,
author = {Jiao, Qiong and Wu, Ling and Wei, Bing and Li, Qing and Su, Xuling and Sun, Keyang and Zhang, Xiaoyue and Luo, Yanli and Liu, Zhiyan},
title = {Diagnostic Utility of a Cost‐Effective Four‐Gene Next Generation Sequencing Panel for Predicting Papillary Thyroid Carcinoma in Indeterminate Thyroid Cytology: A Multicenter Study in China},
journal = {Cancer Medicine},
year = {2026},
doi = {10.1002/cam4.71924}
}
EUVIMED